查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1820152

2025-2033 年止咳糖漿市場報告，按產品類型（祛痰藥、止咳藥/鎮咳藥、複方藥物）、年齡層（兒科、成人）、配銷通路（零售藥房、醫院藥房、網上藥房）和地區分類

Cough Syrup Market Report by Product Type (Expectorants, Cough Suppressants/Antitussives, Combination Medications), Age Group (Pediatric, Adult), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球止咳糖漿市場規模達61億美元。展望未來， IMARC Group預計到2033年，市場規模將達到85億美元，2025-2033年期間的複合年成長率（CAGR）為3.65%。上呼吸道感染（URTI）和其他呼吸系統疾病的發生率不斷上升，加上一般商店和藥局中止咳糖漿的普及，是推動市場成長的主要因素。

全球止咳糖漿市場趨勢：

日益嚴重的醫療狀況

感冒、流感、支氣管炎、百日咳、氣喘、慢性肺阻塞性疾病 (COPD) 和過敏症的盛行率不斷上升，推動了對止咳糖漿的需求。例如，根據《經濟時報》 2023 年發表的一篇文章，全球約有 3.39 億人患有氣喘。此外，由於菸草消費增加和不健康的生活方式導致咳嗽病例增加，也刺激了市場成長。此外，根據世界衛生組織 (WHO) 的數據，每年有超過 800 萬人因吸菸而過早死亡。其中，700 萬人是直接吸菸者，170 萬人是二手菸使用者。因此，政府和非政府組織正在啟動許多計劃和活動，以提高人民的意識。例如，2023 年 7 月，澳洲肺臟基金會發起了一項慢性咳嗽宣傳運動，以提高成人和兒科的認知並支持診斷。除此之外，老年人口的不斷成長也進一步推動了止咳糖漿市場的前景。例如，根據世界衛生組織的數據，2020年60歲及以上人口為10億，預計2050年將達到21億人。

政府機構的監管環境

各國監管機構正在實施嚴格的規定，以確保領先的止咳糖漿公司遵守高醫療標準。為此，他們正在提高醫療保健專業人員開發學名藥的意識，從而催化止咳糖漿市場的新機會。例如，印度藥品監督管理局（DCGI）在致所有邦和聯邦屬地的一封信中要求確保印度生產的止咳糖漿符合全球品質標準，並應進行詳細的驗證。為此，他要求對丙二醇（PG）製造商、止咳糖漿製造商和進口商開展聯合驗證活動，以確保用於生產止咳糖漿的原料符合全球標準。此外，世界衛生組織（WHO）已將另一種止咳糖漿標記為含有污染物。世衛組織在2022年7月收到有關可能存在污染的報告後，對特定批次糖漿的樣本進行了檢測。 Fourrts Laboratories 代表印度另一家名為 Dabilife Pharma 的公司生產了這款止咳糖漿。這些嚴格的法規和檢查將提高產品質量，預計將在未來幾年推動止咳糖漿市場的收入成長。

策略聯盟

知名的關鍵參與者正在進行併購，並不斷致力於開發通常採用天然成分配製而成、具有增強免疫力作用的草藥的新產品。這反過來又推動了市場向前發展。例如，2023 年，葛蘭素史克公司與加拿大的一家生技公司 Bellus Health 簽署了一項價值 20 億美元的收購協議。這筆交易旨在加強葛蘭素史克在全球的臨床產品線組合和市場地位。該產品組合還包括糖漿和其他配方，從而提升了止咳糖漿的市場佔有率。同樣，2023 年 12 月，美國 FDA 發布了關於默克公司針對 gefapixant 的新藥申請 (NDA) 的完整回复函 (CRL)，gefapixant 是治療成人難治性慢性咳嗽 (RCC) 的藥物之一。主要參與者正在進一步推出含有天然成分的止咳糖漿，以擴大其消費者群，這是止咳糖漿市場的最新發展。例如，Vitae Health Innovation 推出了 VITATUSS，這是一款天然糖漿，由接骨木、百里香、蜀葵、錦葵和沙棘萃取物配製而成。同時，Sun Pharmaceutical Industries Ltd. 宣布推出一款名為 Chericof 12 的止咳糖漿。該公司表示，這是印度首款能夠緩解長達 12 小時症狀的處方止咳糖漿。

全球止咳糖漿市場區隔：

按產品類型細分：

  • 祛痰藥
  • 止咳藥/鎮咳藥
  • 聯合用藥

目前，止咳藥/鎮咳藥佔全球大部分市場佔有率

感冒和咳嗽相關症狀通常透過使用非處方藥 (OTC) 來控制。止咳藥或鎮咳藥是用來控制和緩解咳嗽的藥物。雖然許多鎮咳藥是非處方藥，但也有少數鎮咳藥需要處方才能取得。鎮咳藥有各種劑型，例如膠囊、液體、片劑和糖漿。例如，一項雙盲交叉試驗比較了美國最廣泛使用的止咳藥之一右美沙芬與歐洲傳統鎮咳藥可待因，該試驗在16名慢性咳嗽患者中進行了主觀和客觀療效評估。右美沙芬比可待因更能降低咳嗽強度，被大多數患者認為是更好的止痛藥。這反過來又代表了推動止咳糖漿市場在該細分領域成長的關鍵因素。

按年齡層分類：

  • 兒科
  • 成人

成人目前佔據最大的市場佔有率

由於不健康的生活方式和長期接觸菸草，成年人常常患有慢性和急性咳嗽。例如，根據歐洲呼吸學會2020年發布的一項研究，約10%的成年人口因生活品質下降而患有慢性咳嗽。因此，不斷成長的成年人口正在推高止咳糖漿市場的需求，從而刺激止咳藥的普及。

按配銷通路細分：

  • 零售藥局
  • 醫院藥房
  • 網路藥局

目前，零售藥局在市場上佔據明顯主導地位

根據止咳糖漿市場概況，由於零售藥局等分銷管道的便利性和可及性，產品易於獲取，這推動了細分市場的成長。例如，根據德國藥劑師協會聯邦聯盟 (ABDA) 的數據，2023 年，德國約有 18,068 家社區藥局滿足醫療需求。此外，沃爾瑪和沃爾格林等零售連鎖藥局中學名藥和品牌藥數量的不斷增加，也成為另一個重要的成長促進因素。此外，醫院與這些連鎖藥局的合作日益密切，也支撐了止咳糖漿市場的近期價格。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

根據止咳糖漿市場統計數據，亞太地區在市場上佔據明顯主導地位

這份市場研究報告也對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告顯示，亞太地區佔據了最大的市場佔有率。

區域市場主要由製藥公司和政府機構之間的許多合作推動，這些合作通常旨在開發新型學名藥，並提高個人和醫療保健專業人士的認知度。此外，主要參與者正致力於創新包裝解決方案，這也促進了市場的成長。此外，該地區個人消費能力的不斷提升以及對預防性醫療保健的日益重視，進一步驗證了止咳糖漿市場的預測。根據快速消費品專家 (FMCG Gurus) 的報告，自從新冠疫情 (COVID-19) 突然爆發以來，亞太地區超過 55% 的民眾更加重視增強免疫力。

競爭格局：

市場研究報告對競爭格局進行了全面的分析，並提供了所有主要公司的詳細資料。市場中的一些主要參與者包括：

  • Acella製藥有限責任公司
  • 拜耳公司
  • 葛蘭素史克公司
  • 強生公司
  • 輝瑞公司
  • Prestige消費者保健公司
  • 利潔時集團
  • 賽諾菲
  • 太陽製藥工業有限公司
  • 寶潔公司

本報告回答的關鍵問題

  • 2024 年全球止咳糖漿市場規模是多少
  • 2025-2033年全球止咳糖漿市場的預期成長率是多少
  • COVID-19 對全球止咳糖漿市場有何影響
  • 推動全球止咳糖漿市場的關鍵因素有哪些
  • 根據產品類型，全球止咳糖漿市場如何分類
  • 全球止咳糖漿市場按年齡分類的情況如何
  • 根據配銷通路，全球止咳糖漿市場如何分類
  • 全球止咳糖漿市場的主要區域有哪些
  • 全球止咳糖漿市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 2024年全球止咳糖漿市場規模？ 2025-2033年全球止咳糖漿市場的預期成長率是多少？
  • COVID-19 對全球止咳糖漿市場有何影響？
  • 推動全球止咳糖漿市場發展的關鍵因素有哪些？
  • 根據產品類型，全球止咳糖漿市場是如何分佈的？
  • 根據年齡層，全球止咳糖漿市場是如何分佈的？
  • 根據配銷通路，全球止咳糖漿市場如何分佈？
  • 全球止咳糖漿市場的主要地區有哪些？
  • 全球止咳糖漿市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球止咳糖漿市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 祛痰藥
  • 止咳藥/鎮咳藥
  • 聯合用藥

第7章：市場區隔：依年齡段

  • 兒科
  • 成人

第8章：市場區隔：按配銷通路

  • 零售藥局
  • 醫院藥房
  • 網路藥局

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Acella Pharmaceuticals LLC
    • Bayer AG
    • GlaxoSmithKline PLC
    • Johnson & Johnson
    • Pfizer Inc.
    • Prestige Consumer Healthcare Inc.
    • Reckitt Benckiser Group PLC
    • Sanofi
    • Sun Pharmaceutical Industries Limited
    • The Procter & Gamble Company
Product Code: SR112025A3917

The global cough syrup market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.65% during 2025-2033. The increasing occurrence of upper respiratory tract infections (URTIs) and other respiratory disorders, along with the easy availability of cough syrups in general stores and pharmacies, is primarily driving the market growth.

Global Cough Syrup Market Trends:

Growing Medical Conditions

The rising prevalence of cold, flu, bronchitis, pertussis, asthma, chronic pulmonary obstructive disease (COPD), and allergies is driving the need for cough syrups. For example, according to an article published by the Economic Times in 2023, around 339 million individuals are affected by asthma globally. Furthermore, the elevating cough cases, owing to the increasing tobacco consumption and unhealthy lifestyles, are also stimulating the market growth. Besides this, as per the World Health Organization (WHO), every year, more than 8 million people die prematurely from tobacco consumption. Among these, 7 million are direct smokers, and 1.7 million are second-hand smokers. Consequently, government and non-government organizations are launching numerous programs and campaigns to generate awareness among the population. For example, in July 2023, the Lung Foundation in Australia launched a chronic cough awareness campaign to raise awareness and support diagnosis in adults and pediatrics. In addition to this, the expanding geriatric population is further contributing to the cough syrup market outlook. For instance, according to the WHO, individuals aged 60 and above were 1 billion in 2020 and are expected to reach 2.1 billion by 2050.

Regulatory Environment by Government Bodies

Regulatory authorities across countries are implementing stringent rules to ensure leading companies of cough syrups comply with high medical standards. In line with this, they are generating awareness among healthcare professionals to develop generic drugs, thereby catalyzing the cough syrup market recent opportunities. For instance, in a letter written to all states and union territories, the Drugs Controller General of India (DCGI) asked to ensure that cough syrups produced in India are of global standard quality for which a detailed verification should be undertaken. In line with this, he asked for a joint verification drive on propylene glycol (PG) manufacturers, cough syrup manufacturers, and importers to ensure that the raw material utilized or supplied for the manufacturing of cough syrups is as per the global protocol. Additionally, the World Health Organization (WHO) has flagged another cough syrup for the presence of contaminants. The WHO tested a sample from a specific batch of the syrup after it received a report in July 2022 regarding possible contamination. Fourrts Laboratories produced the cough syrup on behalf of another company in India called Dabilife Pharma. These stringent regulations and checks will improve the quality of products, which is expected to propel the cough syrup market revenue in the coming years.

Strategic Alliances

Prominent key players are entering into mergers and acquisitions and are constantly working towards novel product developments that are usually formulated with natural ingredients and herbs with immunity-boosting effects. This, in turn, is driving the market forward. For example, in 2023, GSK plc. signed an acquisition deal with one of the Biotech firms in Canada, Bellus Health, for US$ 2 Billion. This deal was done to strengthen GSK's clinical pipeline portfolio and market position across the globe. The portfolio also included syrups and other formulations, thereby elevating the cough syrup market share. Similarly, in December 2023, the U.S. FDA issued a complete response letter (CRL) about Merck's new drug application (NDA) for gefapixant, one of the drugs to treat refractory chronic cough (RCC) in adults. Key players are further introducing cough syrups with natural ingredients to expand their consumer base, which is cough syrup market recent developments. For instance, Vitae Health Innovation launched VITATUSS, a natural syrup formulated with elderberry, thyme, althaea, mallow, and sea buckthorn extract. In line with this, Sun Pharmaceutical Industries Ltd. announced the introduction of a formulation in cough management called Chericof 12. The company said this was the first prescription cough syrup across India that offer relief for up to 12 hours.

Global Cough Syrup Market Segmentation:

Breakup by Product Type:

  • Expectorants
  • Cough Suppressants/Antitussives
  • Combination Medications

Currently, cough suppressants/antitussives account for the majority of the global market share

Symptoms related to cold and cough are usually managed by utilizing over the counter (OTC) medicines. Cough suppressants, or antitussive drugs, are medicines that are adopted to control and relieve a cough. While many antitussives are widely accessible OTC, a few antitussives are only available with a prescription. Antitussives are used in various types of formulations, such as capsules, liquids, tablets, and syrups. For example, Dextromethorphan, one of the most widely utilized cough suppressants in the U.S., was compared with codeine, the traditional antitussive in Europe, in a double-blind, crossover trial using both subjective and objective assessment of efficacy in sixteen patients with chronic cough. Dextromethorphan lowered cough intensity more than codeine and was considered the better antitussive by most patients. This, in turn, represents key factors propelling the cough syrup market growth in the segmentation.

Breakup by Age Group:

  • Pediatric
  • Adult

Adult currently holds the largest market share

Adults commonly suffer from chronic and acute cough, owing to unhealthy lifestyles and high exposure to tobacco. For example, as per the study published by the European Respiratory Society in 2020, approximately 10% of the adult population suffers from chronic cough, on account of the impaired quality of life. Consequently, the expanding adult population is escalating the cough syrup market demand, thereby stimulating the adoption of cough remedies.

Breakup by Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Currently, retail pharmacy exhibits a clear dominance in the market

As per the cough syrup market overview, the easy product availability via distribution channels, such as retail pharmacy, owing to its accessibility and convenience, is bolstering the segmentation growth. For example, according to the Federal Union of German Associations of Pharmacists (ABDA, around 18,068 community pharmacies across Germany cater to medical needs in 2023. In addition to this, the rising number of generic and branded remedy products in retail pharmacy chains, including Walmart Stores Inc. and Walgreens, is further acting as another significant growth-inducing factor. Moreover, the increasing tie-ups of hospitals with these chains are strengthening the cough syrup market recent price.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

According to the cough syrup market statistics, Asia Pacific exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share.

The regional market is primarily driven by the numerous partnerships among pharmaceutical companies and government organizations, generally to develop novel generic drugs and generate awareness among individuals and healthcare professionals. Moreover, key players are emphasizing on innovative packaging solutions, which is contributing to the growth of the market. Apart from this, the inflating expenditure capacities of individuals across the region and the elevating focus on preventive healthcare are further validating the cough syrup market forecast. According to a report by the FMCG Gurus, more than 55% of people in the Asia Pacific region have been more conscious about boosting their immunity since the sudden outbreak of the COVID-19 pandemic.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Acella Pharmaceuticals LLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • The Procter & Gamble Company

Key Questions Answered in This Report

  • 1.What was the size of the global cough syrup market in 2024?
  • 2.What is the expected growth rate of the global cough syrup market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global cough syrup market?
  • 4.What are the key factors driving the global cough syrup market?
  • 5.What is the breakup of the global cough syrup market based on the product type?
  • 6.What is the breakup of the global cough syrup market based on the age group?
  • 7.What is the breakup of the global cough syrup market based on the distribution channel?
  • 8.What are the key regions in the global cough syrup market?
  • 9.Who are the key players/companies in the global cough syrup market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cough Syrup Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Expectorants
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cough Suppressants/Antitussives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Medications
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Pediatric
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Adult
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Acella Pharmaceuticals LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 GlaxoSmithKline PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Pfizer Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Prestige Consumer Healthcare Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Reckitt Benckiser Group PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sanofi
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 The Procter & Gamble Company
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cough Syrup Market: Major Drivers and Challenges
  • Figure 2: Global: Cough Syrup Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cough Syrup Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cough Syrup Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Cough Syrup Market: Breakup by Age Group (in %), 2024
  • Figure 6: Global: Cough Syrup Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Cough Syrup Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Cough Syrup (Expectorants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Cough Syrup (Expectorants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Cough Syrup (Cough Suppressants/Antitussives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Cough Syrup (Cough Suppressants/Antitussives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Cough Syrup (Combination Medications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Cough Syrup (Combination Medications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Cough Syrup (Pediatric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Cough Syrup (Pediatric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Cough Syrup (Adult) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Cough Syrup (Adult) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Cough Syrup (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Cough Syrup (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Cough Syrup (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Cough Syrup (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Cough Syrup (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Cough Syrup (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Cough Syrup Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Cough Syrup Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Cough Syrup Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Cough Syrup Industry: SWOT Analysis
  • Figure 74: Global: Cough Syrup Industry: Value Chain Analysis
  • Figure 75: Global: Cough Syrup Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cough Syrup Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cough Syrup Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Cough Syrup Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 4: Global: Cough Syrup Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Cough Syrup Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Cough Syrup Market: Competitive Structure
  • Table 7: Global: Cough Syrup Market: Key Players